Collaboration is the key
This article was originally published in Scrip
Executive Summary
The recent news that a new DNA-based vaccine against malaria is entering the clinic is both timely and welcome. Despite the best efforts of the industry, NGOs and a number of philanthropic organisations, progress in controlling and ultimately eliminating this and other diseases blighting the developing world has been painfully slow.